AU2002250845A1 - Pharmaceutical composition for treating multiple sclerosis - Google Patents

Pharmaceutical composition for treating multiple sclerosis

Info

Publication number
AU2002250845A1
AU2002250845A1 AU2002250845A AU2002250845A AU2002250845A1 AU 2002250845 A1 AU2002250845 A1 AU 2002250845A1 AU 2002250845 A AU2002250845 A AU 2002250845A AU 2002250845 A AU2002250845 A AU 2002250845A AU 2002250845 A1 AU2002250845 A1 AU 2002250845A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
multiple sclerosis
treating multiple
treating
sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002250845A
Inventor
Ingo S. Neu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002250845A1 publication Critical patent/AU2002250845A1/en
Abandoned legal-status Critical Current

Links

AU2002250845A 2001-01-26 2002-01-23 Pharmaceutical composition for treating multiple sclerosis Abandoned AU2002250845A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10103506.3 2001-01-26

Publications (1)

Publication Number Publication Date
AU2002250845A1 true AU2002250845A1 (en) 2002-08-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP1450824A4 (en) Pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
EP1408896A4 (en) Pharmaceutical composition
GB0129117D0 (en) Pharmaceutical composition
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
AU2002326991A1 (en) Methods for treating multiple sclerosis
PL370037A1 (en) Pharmaceutical composition
AU2002354460A1 (en) Medicinal composition
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
AUPR529701A0 (en) Pharmaceutical composition
AU2002250845A1 (en) Pharmaceutical composition for treating multiple sclerosis
IL157411A0 (en) Pharmaceutical composition
AU2002342940A1 (en) New pharmaceutical compounds
AU7445601A (en) Pharmaceutical composition for the treatment of multiple sclerosis
AU2003252701A1 (en) Medicinal composition for treating thrombopenia
AU2002100921A4 (en) Pharmaceutical composition
AUPR430501A0 (en) Pharmaceutical composition
AU2002345799A1 (en) Pharmaceutical composition
AU2002354025A1 (en) Pharmaceutical composition
AU2002334736A1 (en) Fondant-based pharmaceutical composition